Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Intelligent Drugs: How AI is Transforming Healthcare - Philippe Moingeon

Intelligent Drugs: How AI is Transforming Healthcare

Buch | Hardcover
XIII, 162 Seiten
2025
Springer International Publishing (Verlag)
978-3-031-91667-0 (ISBN)
CHF 224,65 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

At the end of 2020, in the midst of the COVID-19 crisis, the progress of biotechnologies and artificial intelligence allowed the development of vaccines in less than a year, thus saving millions of human lives and preserving the global economy. The emergence of intelligent drugs is highlighted, with the promise of ultra-targeted, more effective, and safer treatments against a wide range of diseases. Personalized medicine then becomes realistic, with computer-designed drugs, perfectly adapted to each individual, tested on virtual patients before their real use. In the near future, thanks to AI, new drugs will improve physical performance, stimulate cognitive abilities, prevent diseases, and slow down aging.

A fascinating essay to understand the issues and challenges of this medical revolution from which we should all benefit!

Philippe Moingeon is an immunologist, former researcher, and Assistant Professor at Harvard Medical School (Boston, USA), Professor in AI and Health at Paris-Saclay University. He is a member of the French Academy of Pharmacy and an expert with the European Federation of Academies of Medicine on the deployment of AI in health.

 

Preface.- Foreword. The emergence of intelligent drugs. Part One: Drug innovation for the benefit of the patient.- High-tech drugs against COVID-19.- Behind the scenes of an exponential innovation. - Achievements and promises of biotechnologies.-  Breakthrough therapeutic modalities. Part Two: The contributions of artificial intelligence to medicine.- New momentum: Digital health.- The AI-augmented patient.- The predicted drug.- An accelerated evaluation of drugs.- Part Three: The future of medicine in the light of intelligent drugs.- Personalized and preventive medicine.- Stronger, better looking, smarter.- Death of death and rejuvenation pills.- Part Four: New challenges for society.- A refoundation of health systems.- Restoring trust in drugs.- Priority to the human.- Epilogue.

Erscheinungsdatum
Zusatzinfo XIII, 162 p. 2 illus., 1 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Themenwelt Medizin / Pharmazie Allgemeines / Lexika
Schlagworte AI and biotechnologies • Artificial Intelligence • Artificial Intelligence in health • Computational Simulation • Digital twin in health • disease model • drug development • future medicine • generative AI • Industry 4.0 • Innovative drug • machine learning • mixed reality • Pharmaceutical Industry • Precision medicine • Predictive, preventive, participative medicine • virtual patient
ISBN-10 3-031-91667-0 / 3031916670
ISBN-13 978-3-031-91667-0 / 9783031916670
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
medizinischer Grundwortschatz und Fachwörterlexikon für Pflegeberufe

von Karin Deschka; Marc Deschka

Buch | Softcover (2022)
Börm Bruckmeier Verlag
CHF 26,60